Finally, BUB1B is overexpressed in the vast majority of human cancers and knockdown of BUB1B also significantly reduced AIG in cell lines derived from several other cancer types in addition to lung adenocarcinoma. This evidence concerns the gene BUB1B and lung adenocarcinoma.